Michigan Society of Echocardiography 30 th Year Jubilee

Similar documents
Michigan Society of Echocardiography ECHO IN SLOPES How We Do It? Accelerated Dobutamine Echocardiography Henry Ford Initial Experience

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Low Gradient Severe? AS

Comprehensive Echo Assessment of Aortic Stenosis

Stress Testing in Valvular Disease

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Valvular Guidelines: The Past, the Present, the Future

Exercise Testing/Echocardiography in Asymptomatic AS

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Natural History and Echo Evaluation of Aortic Stenosis

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Asymptomatic Valvular Disease:

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress.

The difficult patient with mitral regurgitation

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Usually we DON T need to go beyond the gradient

Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

TAVR: Echo Measurements Pre, Post And Intra Procedure

Sténose aortique à Bas Débit et Bas Gradient

How to Avoid Prosthesis-Patient Mismatch

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

25 different brand names >44 different models Sizes mm

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Indicator Mild Moderate Severe

Nothing to Disclose. Questions. Disclosure Asymptomatic Severe Aortic Stenosis: (When) Should One Intervene? Paul Wood at the Nathanson Lecture, 1958

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Managing the Low Output Low Gradient Aortic Stenosis Patient

Prosthetic valve dysfunction: stenosis or regurgitation

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE


HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Aortic Valve Replacement Improves Outcome in Patients with Preserved Ejection Fraction: PRO!

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Valvular Heart Disease

Spotlight on Valvular Heart Disease Guidelines

Low Gradient AS: Multi-Imaging Modalities

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

Diastolic Heart Function: Applying the New Guidelines Case Studies

Aortic stenosis aetiology: morphology of calcific AS,

Choose the grading of diastolic function in 82 yo woman

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

SONOGRAPHER & NURSE LED VALVE CLINICS

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Objectives. Diastology: What the Radiologist Needs to Know. LV Diastolic Function: Introduction. LV Diastolic Function: Introduction

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

PROSTHETIC VALVE BOARD REVIEW

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

Pathophysiology: Heart Failure

Diastolic Function Overview

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

An Integrated Approach to Study LV Diastolic Function

Management of Difficult Aortic Root, Old and New solutions

How to assess ischaemic MR?

Hemodynamics of Exercise

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Vinod H. Thourani, MD

Diagnosis is it really Heart Failure?

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Disclosures. Stress Echocardiography 2010 Appropriate Use & Further Applications. Stress Echo Clinical Utility 9/8/10

Adult Echocardiography Examination Content Outline

A Health Care Professional s Guide Aortic Stenosis in Seniors

Echocardiographic Evaluation of Mitral Valve Prostheses

Echocardiography as a diagnostic and management tool in medical emergencies

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

HFpEF. April 26, 2018

Exercise PHT in valvular heart disease. Julien Magne CHU Limoges, France

Hypertension in Aortic Valve Disease

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Low gradient severe aortic stenosis with preserved left ventricular ejection fraction

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

Welcome 17 Michigan TAVR Participating Hospitals!

Interventions in Adult Congenital Heart Disease: Role of CV Imaging. Associate Professor. ACHD mortality. Pillutla. Am Heart J 2009;158:874-9

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Relevant Financial Relationship(s) Off Label Usage. None. None

Transcription:

Michigan Society of Echocardiography 30 th Year Jubilee Stress Echocardiography in Valvular Heart Disease Moving Beyond CAD Karthik Ananthasubramaniam, MD FRCP (Glas) FACC FASE FASNC Associate Professor of Medicine Wayne State University Director, Echocardiography and Nuclear Cardiology Program Director, Advanced Cardiac Imaging Fellowship Edith and Benson Ford Heart and Vascular Institute Dept of Medicine, Henry Ford Hospital kananth1@hfhs.org

Disclosures Research Grants : Astellas Pharma Global Development, Inc GE Healthcare Trovis Pharmaceuticals Glaxo-Smith-Kline Speakers Bureau/Honoraria : Astellas Pharma US Inc Lantheus Medical Imaging Consultant/Advisory Board : Lantheus Medical Imaging Astellas Pharma Global Development, Inc No conflicts of interest for this talk

Stress Echo in Valve Disease Who needs testing? What test to do? What parameters to measure and focus on? How to use the information in patient management?

Exertional dyspnea Pulmonary hypertension Coronary artery disease Stress Doppler Echo Mitral valve disease Aortic valve disease Cardiomyopathy Prosthetic valves

Superiority of Stress Echocardiography over ANY OTHER MODALITY Diagnostic Evaluation and Planning strategies for Management in 1Co-existing Valvular Heart Disease 2. Dynamic obstructive disease, 3. Unexplained dyspnea, correlating 4. Exercise hemodynamics to function, pressures and diastology

Exercise Vs Bicycle Echo

Management strategy for patients with severe aortic stenosis Bonow, R. O. et al. J Am Coll Cardiol 2006;48:e1-e148 Copyright 2006 American College of Cardiology Foundation. Restrictions may apply.

Exercise Test in AS : Clinical and EKG Amato et al Heart 2001 ST depression and outcomes Das et al, Eur Heart J 2005 Symptoms and outcomes

Exercise Echo and Outcomes in AS Role of Gradient and EF Reserve Lancelloti et al Circulation 2005 Marechaux et al Echocardiography 2007

Exercise Echo in AS

Stress Data AORTIC STENOSIS Clinical Parameters Symptoms BP response Impact on Outcome Impact on AVR ESC versus ACC guidelines Onset of symptoms indaily life, cardiac death, AVR ESC 1 ESC 2A ACC 2b ACC 2b EKG Vent Arrhythmias ST depression Onset of symptoms in daily life, cardiac death, AVR ESC 2B Echo Increase in mean gradient > 18 ; > 20 mm hg Spontaneous symptoms, cardiac death, AVR Decrease or minimal increase in EF Spontaneous symptoms, cardiac death, AVR

Caveats Increase in transvalvular gradient may not always correlate with presence or onset of symptoms during stress echo in AS Transvalvular gradient depends on 1.severity of AS at rest 2.aortic valve compliance 3.concomitant CAD 4.LV contractile reserve 5.duration of exercise 6.maximal heart rate 7.workload achieved

Newer Stress Parameters in AS Tissue Doppler and Stress Echocardiography Van Pelt et al Heart 2007 Lack of substantial increase in S between rest and exercise as a sign of LV contractile abnormality in AS Correlates with BNP, exercise duration and increase in systolic pressure

Some Formulas EOA ( proj) = EOA res + Valve compliance x ( 250- Q rest ) Valve compliance =slope of the regression equation of the EOA to flow rate( mil/sec) or absolute increase in AVA with dobutamine infusion / increase in flow rate Valve resistance = 1333 x mean gradient / flow rate = SV/ejection time) Stroke work loss = 100 x ( mean gradient /mean gradient +systolic pressure )

Low Flow/Low-Gradient AS Class IIa 1 Dobutamine stress echocardiography is reasonable to evaluate patients with lowflow/low-gradient AS and LV dysfunction. (Level of Evidence: B) 2 Cardiac catheterization for hemodynamic measurements with infusion of dobutamine can be useful for evaluation of patients with lowflow/low-gradient AS and LV dysfunction. (Level of Evidence: C)

Low Flow Low Gradient AS Role of Phamacologic Stress Echo AVA < 1 sq cm MG : <30-<40 mm hg EF < 40%

DSE in Low Flow Low Gradient AS and Normal Ejection Fraction 1. Increasingly recognized and challenging entity 2. EF >/= 50%, low mean gradients < 30 mm hg, AVA < 1 sq cm 3. Low indexed stroke volume, < 35ml/sqm, small concentric remodelled ventricles 4. Important to rule out technical errors prior to making the diagnosis. Consider EOA projected, Zva, Energy Loss index 5.? Role of Dobutamine challenge to increase CO to differentiate

Indications MITRAL STENOSIS Stress Data Parameters Impact on Outcome Impact of decision making ESC and ACC Guidlelines Asymptomatic MS ( MVA < 1.5 sq cm ) Clinical Echo Symptoms or PASP > 60 mm hg exercise testing` ESC 2A ACC1 ACC 1 Symptomatic MS ( MVA < 1.5 sq cm) Echo PASP > 60 or mean mitral gradient> 15 mm hg with exercise Mean mitral gradient > 20 mm hg with DSE Clinical deterioration and need for surgery ACC 2b ACC 2b

At rest there is significant overlap of gradients in patients with varying severity of MS Exercise echo helps to further stratify patients based on their severity Cheriex et al In Jnl of Cardiol 1994

Stress Echo in MS

Stress Echo in MS CAVEATS 1. Atrial fibrillation : importance of averaging 2. Avoidance of use of pressure half time which can be shortened with tachycardia 3. Presence of cocomitant mitral regurgitation which may increase gradient and PA pressure

Exercise Echo in MS

Semi supine Bike

Stress Echo and Mitral Regurgitation Known Severe MR 1. Look for Exercise capacity 2. Pulmonary HTN new / worse 3. LV response Mild or No MR and Unexplained Dyspnea, Pulmonary HTN 1. Exercise capacity 2. New or worsening MR 3. Worsening Pul HTN 4. LV response

Indications MITRAL REGURGITATION Asymptomatic MR Stress Data Parameters Impact on Outcome Clinical -Exercise capacity -Symptoms Development of symptoms Impact of decision making ESC and ACC Guidelines Echo PASP > 60 mm hg with exercise testing` Increase in ERO >/=10 sq mm reduced symptom free survival post-op LV dysfunction ACC 2A Increase in EF < 4 % Increase in LVESV index > 25ml/sq m increase in GLS < 1.9% cardiac morbidity deterioration of LV function Symptomatic MR Echo PASP > 60mm hg ACC 2b Severe MR during exercise

Stress Echo in Ischemic MR LV Parameters Mitral Valve Deformation Parameters MR Parameters LVEDV LVESV LV EF Regional wall thickening Color TDI for dyssynchrony Mitral annulus tenting area Coapation distance ERO Regurgitant volume MR ERO changes with exercise correlate with exercise transtricuspid pressure gradient and increased ERO with exercise correlates with MACE in patients with LV dysfunction and mild MR at rest Exercise echo can unmask severe MR and marked increase in PASP in patients with dyspnea and mild MR. ERO at rest does not correlate with dynamic changes in ERO with exercise Lebrun F et al JACC 2001

Determinants of MV Dynamics Characteristics of Exercise Induced Functional MR (FMR) 1. Greatly varies among patients 2. Des not correlated with FMR at rest 3. Does not correlate with LV dysfunction 4. Mainly correlates with changes in mitral valve deformation 5. Affected by local rather than global LV function and remodelling 6. Favorably affected by recruitable contractile reserve

Functional Mitral Regurgitation : Interplay of Dynamics

Exercise echo in Functional MR

Rest Stress Rest Stress Rest Stress

Stress Echo PE=pulmonary edema FMR=functional MR Bigi et al Cardiovascular Ultrasound 2009

Stress Echo in AI

Stress Echo And Prosthetic Valves Normal prosthetic valves inherently stenotic due to small EOA Type of prosthesis : mechanical versus bioprosthetic /stentless location and annulus size ( aortic) determine gradients Resting gradients tend to overlap for normal and abnormal functioning prosthesis many times In general gradients across prosthetic valves will increase depending on transvalvular flow rate The exaggerated /absolute percentage of increase maybe the most important factor provided by stress echo

Evaluation of St Jude and Medtronic Hall Prosthesis By Stress Echo Small size of aortic prosthesis technical factors contributing to increased gradients across aortic prosthesis Note that normal functioning aortic prosthesis can have substantial increases in gradient with exercise Circulation 1989; 80;116-23

Exercise Gradients in MS and Post MVR with Normal Prosthetic function JACC 1991;17;1520-26 Normal increase of TMG is mild with no or mild increase in EOA by P1/2 time. A 100% or greater increase is likely pathological van de Brink et al Am J Cardiol 1992

Stress Echo in HOCM REST STRESS

REST STRESS Kay Role of Stress Echo in HCM: provocation, hemodynamics, arrhythmias, worsening MR

Exercise Echo and Dyspnea Evaluation In Chronic Lung Disease normal patients chronic lung disease and normal resting PA pressures chronic lung disease and abnormal resting PA pressures Imp : regardless of PASP pts with chronic lung disease have exercise induced increase in PASP reflecting abnormal PVR

Exercise Echo in Dyspnea Evaluation

Dynamic Diastology with Exercise E E E/E Normal DFP DFP diastolic filling pressure

THANK YOU kananth1@hfhs.org